Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDX-1197 in HRR Mutated Solid Tumors
NCT04174716Phase 2Completed
- Sponsor
- Idience
- Start
- Nov 2019
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of venadaparib in solid tumor, sponsored by Idience. Started Nov 2019; status: completed.
02
Drugs
venadaparib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT04174716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04174716.